Evaluation and Treatment of Patients With Dermatologic Diseases

Launched by NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES (NIAMS) · Nov 3, 1999

Keywords

ClinConnect Summary

This clinical trial is focused on understanding and treating skin diseases, including those related to other health conditions that show symptoms on the skin. It aims to gather information about how these diseases progress and how well different treatments work. Patients of all ages, genders, and backgrounds who have skin conditions or related systemic diseases may be eligible to participate. However, pregnant or breastfeeding women will only take part if the tests and medications are proven to be safe for their babies. Each participant will need a doctor who will manage their overall care during and after the trial.

Participants can expect a thorough evaluation and treatment using standard medical practices. They will undergo tests and procedures that involve collecting samples of blood and skin, which will be analyzed to help establish their diagnosis and track their response to treatment. This study is currently looking for volunteers, and it’s important to note that anyone who might struggle to follow the study requirements or could face higher medical risks will not be included.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• • Patients of any age (only viable neonates will enroll in the study), of both genders, and all racial/ethnic groups with dermatologic diseases or systemic diseases with cutaneous manifestations that will help the Branch fulfill the objectives.
• • Women who are pregnant or lactating, will only undergo tests and procedures, and/or receive medications for which data exists proving minimal risk to the fetus and/or child.
• • Patients must have a referring physician who will continue to assume primary medical responsibility of care for the patient during and after enrollment in this protocol.
• EXCLUSION CRITERIA:
• • Any participant who, in the investigator s opinion, would be unable to comply with study requirements or for whom participation may pose a greater medical risk.